CT-0525 is the first CAR-Monocyte to be evaluated in humans in the solid tumor setting
First patient expected to be treated in the first half of 2024
https://www.prnewswire.com/news-releases/carisma-therapeutics-announces-fda-clearance-of-ind-application-for-ct-0525-a-novel-her2-targeting-car-monocyte-301998422.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.